BR-Where do you expect the share price to be (if), Pona is clearly headed for approval and likelihood of 1st line penetration (some) is increasing...... at the same time 113 shows very strong efficacy... at year end 2012...Maybe you don't agree with this scenario but I would still be interested to know your thoughts on the hypothetical.....
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.